BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
1-Year Return
17.27%
This Quarter Return
+7.49%
1 Year Return
+17.27%
3 Year Return
+58.16%
5 Year Return
+110.76%
10 Year Return
+270.98%
AUM
$9.72B
AUM Growth
+$589M
(+6.4%)
Cap. Flow
-$38.9M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9
Top Buys
| 1 |
Amgen
AMGN
|
+$47.4M |
| 2 |
AbbVie
ABBV
|
+$41.8M |
| 3 |
Chevron
CVX
|
+$23.1M |
| 4 |
Sempra
SRE
|
+$21.6M |
| 5 |
HP
HPQ
|
+$20.9M |
Top Sells
| 1 |
Merck
MRK
|
+$69.7M |
| 2 |
Enbridge
ENB
|
+$62.3M |
| 3 |
Microsoft
MSFT
|
+$47.4M |
| 4 |
Kimberly-Clark
KMB
|
+$43.6M |
| 5 |
Virtu Financial
VIRT
|
+$10.4M |
Sector Composition
| 1 | Technology | 17.92% |
| 2 | Healthcare | 16.37% |
| 3 | Financials | 13.94% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Staples | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sabre
SABR
$686M
| $2.25M | 0.02% |
109,858
+39,182
| +55% | +$803K |
|
|
PF
202
DELISTED
Pinnacle Foods, Inc.
PF
| $2.24M | 0.02% |
37,741
+8,366
| +28% | +$497K |
|
203
Oracle
ORCL
$670B
| $2.18M | 0.02% |
46,086
+800
| +2% | +$37.8K |
|
|
RAVN
204
DELISTED
Raven Industries Inc
RAVN
| $2.18M | 0.02% |
63,336
-345
| -0.5% | -$11.8K |
|
205
Flowers Foods
FLO
$3.15B
| $2.15M | 0.02% |
111,338
+32,186
| +41% | +$622K |
|
206
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $2.14M | 0.02% |
56,420
-680
| -1% | -$25.8K |
|
207
Cracker Barrel
CBRL
$1.13B
| $2.09M | 0.02% |
13,161
+2,659
| +25% | +$422K |
|
208
Cinemark Holdings
CNK
$3.16B
| $2.09M | 0.02% |
60,013
+6,054
| +11% | +$211K |
|
209
iShares Russell 2000 ETF
IWM
$67.9B
| $2.06M | 0.02% |
13,508
+5,202
| +63% | +$793K |
|
|
PDCO
210
DELISTED
Patterson Companies, Inc.
PDCO
| $2.05M | 0.02% |
56,638
+4,607
| +9% | +$166K |
|
211
LeMaitre Vascular
LMAT
$2.2B
| $2.03M | 0.02% |
63,825
+820
| +1% | +$26.1K |
|
|
TCF
212
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.03M | 0.02% |
+37,872
| New | +$2.03M |
|
213
NVE Corp
NVEC
$324M
| $2.02M | 0.02% |
23,466
-50
| -0.2% | -$4.3K |
|
214
BCE
BCE
$22.7B
| $2.01M | 0.02% |
41,852
-113
| -0.3% | -$5.43K |
|
215
Gilead Sciences
GILD
$144B
| $1.99M | 0.02% |
27,716
+3,000
| +12% | +$215K |
|
216
Vanguard FTSE Emerging Markets ETF
VWO
$98.1B
| $1.98M | 0.02% |
43,102
+8,805
| +26% | +$404K |
|
217
US Physical Therapy
USPH
$1.29B
| $1.97M | 0.02% |
27,335
+700
| +3% | +$50.6K |
|
218
Pricesmart
PSMT
$3.44B
| $1.95M | 0.02% |
22,610
-140
| -0.6% | -$12.1K |
|
219
West Pharmaceutical
WST
$18.2B
| $1.91M | 0.02% |
19,363
-2,075
| -10% | -$205K |
|
220
Texas Pacific Land
TPL
$21B
| $1.88M | 0.02% |
12,600
| – | – |
|
221
UFP Industries
UFPI
$6.01B
| $1.87M | 0.02% |
49,790
+1,010
| +2% | +$38K |
|
|
MDSO
222
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.81M | 0.02% |
28,505
+7,279
| +34% | +$461K |
|
223
Hillenbrand
HI
$1.81B
| $1.8M | 0.02% |
40,170
| – | – |
|
224
Brown-Forman Class B
BF.B
$13B
| $1.78M | 0.02% |
40,513
| – | – |
|
225
Methode Electronics
MEI
$255M
| $1.77M | 0.02% |
44,200
-915
| -2% | -$36.7K |
|